Dentists in West Newton, PA Accepting Medicare
1 Dentists found. Showing 1 - 1
 Dr. Walter F Shutty, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 303 S 6th St, West Newton, PA 15089 Phone: 724-872-4818 |
News Archive
National Day of Action to be celebrated on September 26
Saturday, September 26 officially has been designated as National Day of Action, in support of National Pain Awareness Month. To help promote awareness of chronic pain and how to access help, Valley Pain Specialists, an 11-member physicians group of board-certified, fellowship-trained pain medicine specialists, are launching a speaking circuit where they plan to meet with groups of patients and physicians throughout the community to raise awareness about pain, highlight the issues surrounding pain management and address the lack of access to pain care.
Chemotherapy during pregnancy for cancer does not necessarily harm the baby: Study
When a pregnant woman is diagnosed with cancer, she and her family and doctors are faced with difficult decisions about her health and that of her unborn child. It is known that giving chemotherapy in the first 12 weeks, when the baby's organs are still forming, raises the chances of birth defects. Postponing the treatment, however, could allow the cancer to spread. Over the last decade, doctors have been more willing to use chemotherapy after the first trimester, but there have been worries that the child's brain and heart could suffer damage.
Study: Offering flu vaccines at elementary schools could expand vaccination rates, reduce costs
Offering flu vaccines at elementary schools could expand vaccination rates and reduce costs, according to a new study reported in the scientific journal Vaccine by researchers from UC Davis Health System; the Monroe County, New York, Department of Public Health; University of Rochester Medical Center; and U.S. Centers for Disease Control and Prevention.
Medivir, Bristol-Myers Squibb to initiate TMC435 and daclatasvir phase II combination study in HCV
Medivir AB, the research-based pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that a phase II combination study with the investigational compound TMC435 and Bristol-Myers Squibb's investigational compound daclatasvir will start in July.
Stellenbosch University and AzarGen Biotechnologies join forces to tackle COVID-19
Stellenbosch University in South Africa and AzarGen Biotechnologies (Pty) Ltd, a South African biotechnology company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants, have joined forces in the global fight against the coronavirus.
› Verified 6 days ago